Concepedia

Tuo Meng

TM

Statistics

Publications

12

Citations

536

H-Index

11

Active since

2016

Affiliations

Virginia Commonwealth University(Current)

Johns Hopkins Medicine

Johns Hopkins University

Sun Yat-sen University

Eye & ENT Hospital of Fudan University

Tuo Meng is an author at Virginia Commonwealth University specializing in nanoparticle drug delivery, pharmacy, and drug delivery.

ORCID

Publications per year

2016–2024

12

Publications

12

Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration

Fangfang Qiu, Tuo Meng, Qian Chen et al. · Molecular Pharmaceutics · 2019 · 125 citations · Full text

, , +17

Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner

Qingran Li, Chujie Ding, Tuo Meng et al. · Journal of Pharmacological Sciences · 2017 · 99 citations · Full text

, , +17

Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis

Lixia Luo, Jin Yang, Yumin Oh et al. · Journal of Controlled Release · 2019 · 78 citations

, , +16

Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization

Bing Wang, Ya-Ting Tang, Yumin Oh et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 44 citations · Full text

, , +17

Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats

Jin Yang, Lixia Luo, Yumin Oh et al. · Journal of Controlled Release · 2020 · 42 citations · Full text

, , +14

1–5 of 12